<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:chebi fb="0" ids="30153">BH3</z:chebi>-only protein <z:chebi fb="0" ids="50397">NOXA</z:chebi> represents one of the critical mediators of DNA-damage-induced cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In particular, its involvement in cellular responses to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> chemotherapy is increasingly evident </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we identify a strategy of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells to escape genotoxic chemotherapy by increasing proteasomal degradation of <z:chebi fb="0" ids="50397">NOXA</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>We show that the deubiquitylating enzyme UCH-L1 is a key regulator of <z:chebi fb="0" ids="50397">NOXA</z:chebi> turnover, which protects <z:chebi fb="0" ids="50397">NOXA</z:chebi> from proteasomal degradation by removing Lys(48)-linked polyubiquitin chains </plain></SENT>
<SENT sid="4" pm="."><plain>In the majority of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> from patients with <z:hpo ids='HP_0002861'>melanoma</z:hpo> or <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> suffering from high rates of chemoresistance, <z:chebi fb="0" ids="50397">NOXA</z:chebi> fails to accumulate because UCH-L1 expression is epigenetically silenced </plain></SENT>
<SENT sid="5" pm="."><plain>Whereas UCH-L1/<z:chebi fb="0" ids="50397">NOXA</z:chebi>-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples exhibit increased sensitivity to genotoxic chemotherapy, downregulation of UCH-L1 or inhibition of its deubiquitylase activity resulted in reduced <z:chebi fb="0" ids="50397">NOXA</z:chebi> stability and resistance to genotoxic chemotherapy in both human and C. elegans cells </plain></SENT>
<SENT sid="6" pm="."><plain>Our data identify the UCH-L1/<z:chebi fb="0" ids="50397">NOXA</z:chebi> interaction as a therapeutic target for overcoming <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> chemoresistance </plain></SENT>
</text></document>